Correlation Between Elanco Animal and Innate Pharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Elanco Animal and Innate Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Elanco Animal and Innate Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Elanco Animal Health and Innate Pharma, you can compare the effects of market volatilities on Elanco Animal and Innate Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Elanco Animal with a short position of Innate Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Elanco Animal and Innate Pharma.

Diversification Opportunities for Elanco Animal and Innate Pharma

0.64
  Correlation Coefficient

Poor diversification

The 3 months correlation between Elanco and Innate is 0.64. Overlapping area represents the amount of risk that can be diversified away by holding Elanco Animal Health and Innate Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Innate Pharma and Elanco Animal is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Elanco Animal Health are associated (or correlated) with Innate Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Innate Pharma has no effect on the direction of Elanco Animal i.e., Elanco Animal and Innate Pharma go up and down completely randomly.

Pair Corralation between Elanco Animal and Innate Pharma

Given the investment horizon of 90 days Elanco Animal Health is expected to generate 0.43 times more return on investment than Innate Pharma. However, Elanco Animal Health is 2.33 times less risky than Innate Pharma. It trades about 0.08 of its potential returns per unit of risk. Innate Pharma is currently generating about -0.1 per unit of risk. If you would invest  1,264  in Elanco Animal Health on September 1, 2024 and sell it today you would earn a total of  57.00  from holding Elanco Animal Health or generate 4.51% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Elanco Animal Health  vs.  Innate Pharma

 Performance 
       Timeline  
Elanco Animal Health 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Elanco Animal Health has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's basic indicators remain healthy and the recent disarray on Wall Street may also be a sign of long period gains for the firm investors.
Innate Pharma 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Innate Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unfluctuating performance in the last few months, the Stock's technical indicators remain somewhat strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.

Elanco Animal and Innate Pharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Elanco Animal and Innate Pharma

The main advantage of trading using opposite Elanco Animal and Innate Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Elanco Animal position performs unexpectedly, Innate Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Innate Pharma will offset losses from the drop in Innate Pharma's long position.
The idea behind Elanco Animal Health and Innate Pharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.

Other Complementary Tools

Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Fundamental Analysis
View fundamental data based on most recent published financial statements
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators